April 19, 2016
Venlo, The Netherlands – QIAGEN N.V. (”NASDAQ: QGEN; Frankfurt Prime Standard: QIA”) announced on 29 March 2016 that QIAGEN N.V had decided to make a conditional, voluntary public tender offer for the shares of Exiqon A/S in which the shareholders of Exiqon are offered a cash amount of DKK 18 for each share they hold [...]
Exiqon publishes Takeover Offer Document
April 19, 2016
Copenhagen, - Exiqon A/S (Nasdaq Copenhagen: “EXQ”) announced on behalf of QIAGEN N.V the submission of a takeover offer to buy the entire share capital of Exiqon A/S. The price offered is DKK 18.00 per share of nominal DKK 1.00. The offer is valid until 18 May 2016 at 23.59 (CET). Please find enclosed a [...]
Analytik Jena Sells Site in Eisfeld
April 19, 2016
Jena/Eisfeld, – Analytik Jena AG is selling its Eisfeld site as of the end of April 30, 2016, to NOBLEX GmbH. NOBLEX GmbH is a subsidiary of the Frankfurt-based investment company VF Capital GmbH. A corresponding agreement was signed this past Friday by both companies. In addition to the business with optical consumer products under [...]
Collagen Solutions Plc Supplies Collagen Materials to Merck
April 19, 2016
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announced that it has completed a supply agreement with Merck Ag. Under the agreement, researchers worldwide will have access to Collagen Solutions' medical-grade collagen products through Merck's broad distribution network. Dr. [...]
Crowder resigns as Neogen director
April 18, 2016
LANSING, Mich., — Neogen Corporation (NASDAQ: NEOG) announced that Dr. Richard Crowder has resigned as a member of the company’s Board of Directors, effective April 30. Crowder, 77, resigned for personal reasons. Crowder has been a member of the Board of Directors since 2009 and was elected to a new three-year term in October 2015. [...]
April 18, 2016
MILFORD, Mass., - SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers, announced at the American Association for Cancer Research the launch of an expanded product line to support Next-Generation Sequencing (NGS)-based somatic tumor profiling assay development, validation, and QC performance monitoring. The Seraseq™ Solid Tumor Mutation Mix family of [...]
April 18, 2016
SAN DIEGO, Calif., - Agena Bioscience announced the commercial availability of iPLEX® HS, a new chemistry that enables highly sensitive, multiplexed detection of genetic variants present in solid tumors. iPLEX HS, unveiled today at the American Association of Cancer Research conference, provides cancer researchers a unique combination of sensitivity and ease-of-use for targeted genetic analysis [...]
Zymo Research Launches FFPE DNA and RNA Purification Kits at AACR
April 18, 2016
NEW ORLEANS, - Zymo Research Corporation will introduce the newest in its line of FFPE kits, Quick-DNA™ FFPE Kit and Quick-RNA™ FFPE Kit, for DNA and RNA purification during the AACR 2016 Annual Meeting. These kits provide a simple and reliable method for isolating total nucleic acids (DNA, RNA, including small DNA and RNA species) [...]
LGS Innovations Awarded $11.2M Air Force Contract to Develop Remote Chemical Sensor
April 18, 2016
Herndon, Va. — LGS Innovations announced it has been awarded a four-year, $11.2M cost-plus-fixed-fee contract to develop a compact, laser-based system to aid in the detection of chemical weapons, biological agents, explosives, narcotics, and chemical indicators of nuclear material development. The U.S. Air Force Research Laboratory at Wright-Patterson Air Force Base, Ohio, announced that LGS [...]
Ranomics BRCA1 RING-Domain Variant Database Launch
April 18, 2016
Ranomics, a Toronto based biotech startup with a mission to resolve Variants of Unknown Significance (VUS) in genetic testing results, launches Ranomics RING-Domain., Ranomics RING domain is a first-in-class database of functional studies for 2,000 variants of BRCA1, a commonly mutated gene in hereditary breast and ovarian cancers. The database will hugely impact VUS resolution [...]
